Different Glycemic Index (GI) Values in 7 Food Products

In-Vivo Glycemic Index (GI) and Insulinemic Index (II) Testing of 7 Test Foods in Total (5 Milk-based Beverage and 2 Standard Breakfast Items)

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02278380

Enrollment

Registered

2014-10-30

Start date

2014-06-30

Completion date

2015-01-31

Last updated

2015-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glycemic Index

Brief summary

This study is initiated to investigate the glycemic index value of seven food products.

Interventions

OTHERLow GI Standard Breakfast

Low GI Standard Breakfast

OTHERMedium GI Standard Breakfast

Medium GI Standard Breakfast

OTHEREnfamama A+

Nutritional pregnant milk supplement

OTHERGlucerna Triple Care

Nutritional product for diabetics

OTHERDumex Precima

Pregnant and lactation women milk powder

OTHERDiasip

Nutritional drinks for diabetics

OTHERTest product

Test product not patented yet

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

21 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* Healthy males or non-pregnant females at least 6 weeks postpartum, non-lactating and aged 21-60yrs old in both groups. * They should not suffer from any chronic diseases. * no known food allergy or intolerance. * no medications known to affect glucose tolerance(excluding oral contraceptives). Note: stable doses of oral contraceptives, acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis are acceptable.

Exclusion criteria

* Age less than 21 years old and greater than 60 years old. * known history of diabetes mellitus or the use of antihyperglycemic drugs or insulin to treat diabetes and related conditions. * known history of AIDS, hepatitis, renal or heart disease or any other serious complications that may interfere with glucose metabolism. * subjects using any medication (eg steroids, protease inhibitors or antipsychotics, etc.) that would interfere with the digestion and nutrient absorption., * subjects having gastrointestinal diseases that may interfere with nutrient absorption, distribution, metabolism, excretion and have no known food allergies. * a major medical or surgical event requiring hospitalisation within the preceding 3 months.

Design outcomes

Primary

Measure	Time frame	Description
Glycemic index values of all seven products	120 minutes post administration	Glycemic index values at 120 minutes post adminstration.

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026